Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer

This study has been terminated.
(slow accrual)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Comprehensive Cancer Center of Wake Forest University Identifier:
First received: January 15, 2010
Last updated: February 17, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)